JWJie Wang

Jie Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jie Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pearls & Oy-sters: Recurrent Stroke From a Nonstenotic Carotid Plaque

    by Jie Wang, Bin Yang, Wei Gao, Yan Ma, Liqun Jiao

    In the etiologic assessment of ischemic stroke, conventional imaging techniques may underestimate the clinical significance of high-risk plaques that do not exhibit significant luminal stenosis. Here, we report the case of a 66-year-old male patient who experienced 3 recurrent strokes. Carotid ultrasound and digital subtraction angiography showed no apparent carotid stenosis. However, high-resolution MRI and postoperative pathology revealed a plaque in the common carotid artery with vulnerable features including positive remodeling, fibrous cap rupture, and intraplaque hemorrhage. This case highlights that vulnerable plaques can pose a risk of stroke even when stenosis is only mild and underscores the pivotal role of high-resolution imaging techniques in identifying plaque characteristics to refine stroke etiology assessment. This case provides valuable insight into the high-risk nature of nonstenotic plaques and supports the optimization of stroke risk stratification strategies.


  • CT Perfusion for Predicting Ischemic Stroke in Patients With Symptomatic Carotid or Middle Cerebral Artery Occlusion: A Post Hoc Analysis of the CMOSS Study

    by Tao Wang, Yifan Yang, Haibo Wang, Delin Liu, Jie Wang, Jichang Luo, Renjie Yang, Tianhua Li, Haozhi Gong, Xinyi Sun, et al.

    BACKGROUND: It is unknown whether computed tomographic perfusion (CTP) parameters predict ischemic stroke in patients with symptomatic chronic carotid or middle cerebral artery occlusion. METHODS: A post hoc analysis of medically treated patients enrolled in the CMOSS trial (Carotid or Middle Cerebral Artery Occlusion Surgery Study; URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01758614), a randomized controlled trial conducted at 13 centers in China between June 2013 and March 2018. It aimed to compare extracranial-intracranial bypass surgery to medical therapy in patients with symptomatic carotid or middle cerebral artery occlusion and hemodynamic insufficiency. CTP-derived mean transit time and relative cerebral blood flow were collected. The primary outcome was defined as ischemic stroke in the territory of the qualifying artery within 2 years after randomization. The predictive value of CTP for the primary outcome was analyzed by a Cox regression model. Receiver operating characteristic curves were used to calculate optimal cutoff values of CTP parameters. RESULTS: All 165 per-protocol patients (median age=53.7 years, 81.2% men) treated with medical treatment alone were analyzed. Sixteen (9.7%) patients suffered the primary outcome during the 2-year follow-up. Cutoff values of mean transit time >6.5 seconds (symptomatic side) and relative cerebral blood flow ≤0.5 were associated with recurrent stroke. In multivariate Cox regression, mean transit time (adjusted hazard ratio, 3.50 [95% CI, 1.19–10.30]; P =0.02) and relative cerebral blood flow (adjusted hazard ratio, 7.36 [95% CI, 2.27–23.85]; P =0.001) were independently associated with the primary outcome. CONCLUSIONS: CTP-based hemodynamic parameters are predictive of recurrent ischemic stroke in symptomatic patients with chronic carotid or middle cerebral artery occlusion. CTP could be used in patient selection for stratified secondary prevention of stroke in future studies. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01758614.


  • Endovascular Therapy Versus Medical Treatment for Symptomatic Intracranial Artery Stenosis

    by Jichang Luo, Tao Wang, Kun Yang, Xue Wang, Ran Xu, Haozhi Gong, Xiao Zhang, Jie Wang, Renjie Yang, Peng Gao, et al.


  • Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Systematic Review and Meta-Analysis

    by Jie Wang, Xuesong Bai, Tao Wang, Adam A. Dmytriw, Aman B. Patel, Liqun Jiao

    Background: To compare safety and efficacy between carotid artery stenting (CAS) and carotid endarterectomy (CEA) in treating asymptomatic carotid artery stenosis based on results from randomized controlled trials. Methods: Randomized controlled trials comparing CAS and CEA in treating asymptomatic carotid artery stenosis were searched from databases of the EMBASE, PubMed, MEDLINE, and Cochrane libraries. Two independent reviewers identified eligible studies, extracted relevant data, and used the Cochrane risk of bias tool to assess quality. Mantel-Haenszel method random-effects models were used to estimate odds ratio (OR) regarding perioperative risks between CAS and CEA. Kaplan-Meier curve data were extracted and analyzed through Exp[(O-E)/Var] fixed-effect models to calculate the Peto odds ratio (OR) regarding long-term outcomes. Results: Sixteen articles from 7 randomized controlled trials were included, reporting relevant outcomes for 7118 asymptomatic carotid artery stenosis patients (CAS: n=3920; CEA: n=3198). Compared with the CEA group, CAS group had no difference in perioperative composite end point events including stroke, death, and myocardial infarction (MI; OR, 1.13 [95% CI, 0.87–1.47]; P =0.37, I 2 =0%). Compared with CEA, CAS had a higher risk of any stroke during the perioperative period (OR, 1.62 [95% CI, 1.16–2.24]; P =0.004, I 2 =0%) and an increased risk of nondisabling stroke (OR, 1.81 [95% CI, 1.23–2.65]; P =0.003, I 2 =0%), but there was no significant difference in disabling stroke and death between groups (OR, 0.91 [95% CI, 0.50–1.65]; P =0.76, I 2 =0%). For long-term outcomes, no difference regarding the composite outcome of any stroke, death, and myocardial infarction existed between CEA and CAS (Peto OR, 1.18 [95% CI, 0.94–1.48]; P =0.14, I 2 =0%). Individual-level patient data would be important to verify the long-term outcome results. Conclusions: When treating asymptomatic carotid artery stenosis, CAS has comparable perioperative and long-term composite outcomes compared with CEA. However, CAS may have a higher risk of any stroke and nondisabling stroke in the perioperative period.